FIREFLY NEUROSCIENCE, INC.

Firefly Neuroscience, Inc. is an artificial intelligence company focused on precision neuroscience. The company uses AI and extensive electrophysiological data to provide clinicians with a comprehensive and objective view of individual brain function. Firefly Neuroscience aims to improve how electrophysiological data is used in clinical decisions for brain health. The company developed the Firefly Platform, which integrates hardware, software, and data infrastructure. This platform captures standardized electroencephalographic (EEG) and event-related potential (ERP) assessments directly at the point of care. It then analyzes this data using a proprietary analytics engine and delivers structured, clinician-ready reports to providers through a single workflow. Each scan contributes to and enhances the company's database, and each new clinic joining its network increases the depth and diversity of its data. This relationship between clinical deployment, data acquisition, and report quality is referred to as the Firefly Flywheel. As of December 31, 2025, the company's FDA-510(k) cleared Evoke System is actively used in over 85 clinical sites in the United States. Clinicians utilize this system for EEG and ERP assessments, which are analyzed by the company's cloud-based platform and returned as structured reports to aid clinical decision-making. Firefly Neuroscience operates on a subscription-based commercial model, generating recurring revenue that increases with clinical utilization. This means that as clinicians integrate electrophysiological assessment more deeply into their practice, the company generates more revenue and its database expands.